financetom
Business
financetom
/
Business
/
Arch Capital Group Insider Sold Shares Worth $4,374,025, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arch Capital Group Insider Sold Shares Worth $4,374,025, According to a Recent SEC Filing
Mar 7, 2024 2:39 PM

05:26 PM EST, 03/07/2024 (MT Newswires) -- Maamoun Rajeh, Chairman and Chief Executive Officer of Arch Reinsurance Group, on March 05, 2024, sold 50,000 shares in Arch Capital Group ( ACGL ) for $4,374,025. Following the Form 4 filing with the SEC, Rajeh has control over a total of 336,170 shares of the company, with 336,170 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/947484/000141588924007200/xslF345X03/form4-03072024_100359.xml

Price: 87.8, Change: +0.11, Percent Change: +0.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chile must pass permitting reforms to unblock investment: BHP
Chile must pass permitting reforms to unblock investment: BHP
Apr 16, 2024
SANTIAGO, April 16 (Reuters) - Chile's government needs to quickly approve a proposal to streamline permitting for the mining industry to unlock and promote investment in the world's top copper-producing country, a top BHP official said on Tuesday In Chile it is urgent to improve the permit system to allow companies to approve large investment projects in a timely manner,...
Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%
Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%
Apr 16, 2024
Calidi Biotherapeutics Inc ( CLDI ) shares are trading lower by 59% to $0.25 during Tuesday’s session after the company announced the pricing of a $6.1 million public offering. The offering includes various types of warrants with different exercise prices and expiration dates. The company plans to use the net proceeds for working capital, general corporate purposes, and pre-clinical and...
Why Palisade Bio Stock Is Soaring Today
Why Palisade Bio Stock Is Soaring Today
Apr 16, 2024
Palisade Bio, Inc. ( PALI ) shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bioactivation of PALI-2108. The Details: Palisade Bio ( PALI ) said the findings demonstrated PALI-2108 exhibited efficient ex-vivo conversion into its active PDE4 inhibitor form in stool samples from both normal healthy volunteers and patients with ulcerative colitis...
Why Jaguar Health Stock Is Up Today
Why Jaguar Health Stock Is Up Today
Apr 16, 2024
Jaguar Health, Inc. ( JAGX ) shares are trading higher Tuesday after the company announced it has signed an exclusive 5-year in-license agreement with Venture Life Group PLC. The Details: The license agreement is for the U.S. market for Venture Life's FDA-approved prescription product, Gelclair. Gelclair is used for the treatment of oral mucositis, also called “chemo mouth.”  “We are...
Copyright 2023-2026 - www.financetom.com All Rights Reserved